A Study in Migraine Prevention

NCT01184508 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

87

Enrollment

INDUSTRY

Sponsor class

Stopped Elevation of ALT and AST in some patients.

Conditions

Migraine Headache

Interventions

DRUG: Placebo
DRUG: LY2300559

Sponsor

Eli Lilly and Company